LP
LIGAND PHARMACEUTICALS
LGND· Health Care· BiotechnologyS&P 600
Close · 13/11/2026
308.79
1D
-2.37%52-week range
175.89 – 326.63
Volume
1,30,700.00
Price history
LGND
15/10/2026 to 13/11/2026
O 313.98 H 314.79 L 308.59
1W+0.85%
1M+3.45%
3M+5.83%
6M+44.83%
1Y+50.18%
3Y+491.21%
5Y+223.08%
MAX+271.59%
Fundamentals
as of 13/11/2026- Market cap
- $6.18B
- Shares out
- 20.00M
- P/E (trailing)
- 120.02
- P/E (forward)
- 25.83
- EPS (trailing)
- 2.57
- Dividend yield
- 0.00%
- Beta
- 1.04
- Profit margin
- 20.27%
- P/B
- 6.42
- Return on equity
- 5.35%
SEC financial statements
62 quarterly and 17 annual periods through 30/09/2026.
Details
- Ticker
- LGND
- Index
- SP600
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
1 filer · 0 on watchlist · 4 buys · 0 sells · D: 4
- 29/05/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/03/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 15/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 05/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000